🇺🇸 FDA
Pipeline program

QVM149

ROB0045

Phase 3 small_molecule terminated

Quick answer

QVM149 for Asthma is a Phase 3 program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Grace Therapeutics
Indication
Asthma
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials